In vitro Quality of Platelets with Low Plasma Carryover Treated with Ultraviolet C Light for Pathogen Inactivation | Zendy

Lacey Johnson | Zendy; Ryan A. Hyland | Zendy; Shereen Tan | Zendy; Frank Tolksdorf | Zendy; Chryslain Sumian | Zendy; Axel Seltsam | Zendy; Denese C. Marks | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro Quality of Platelets with Low Plasma Carryover Treated with Ultraviolet C Light for Pathogen Inactivation

Author(s) -

Lacey Johnson,

Ryan A. Hyland,

Shereen Tan,

Frank Tolksdorf,

Chryslain Sumian,

Axel Seltsam,

Denese C. Marks

Publication year - 2015

Publication title -

transfusion medicine and hemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.971

H-Index - 39

eISSN - 1660-3818

pISSN - 1660-3796

DOI - 10.1159/000441830

Subject(s) - platelet , in vitro , pathogen , ultraviolet , platelet rich plasma , chemistry , microbiology and biotechnology , medicine , immunology , biology , biochemistry , materials science , optoelectronics

The THERAFLEX UV-Platelets system uses shortwave ultraviolet C light (UVC, 254 nm) to inactivate pathogens in platelet components. Plasma carryover influences pathogen inactivation and platelet quality following treatment. The plasma carryover in the standard platelets produced by our institution are below the intended specification (<30%).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research